• No results found

Differences between the data in the electronic medical record, the prescriptions stored in the Swedish national prescription repository and and the patient’s knowledge of the present treatment

N/A
N/A
Protected

Academic year: 2022

Share "Differences between the data in the electronic medical record, the prescriptions stored in the Swedish national prescription repository and and the patient’s knowledge of the present treatment"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Differences between the data in the electronic medical record, the prescriptions stored in the Swedish national prescription repository and the current treatment stated by the patients

Helen Brosius (1), Julia Jönsson (1), Hanna Karlsson (1), Maria Yngvesson (2), Anders Ekedahl (1, 3),

1 Linneus University, Kalmar, 2 Stensö HC, Kalmar 3 R&D Department, National Corporation of Swedish Pharmacies, Malmö, Sweden

Background: Misuse and medication errors are common causes of patient morbidity. Patient adherence to prescribed treatment for chronic conditions has been estimated to be on average about 50% (1), drug related problems may cause as much as 30% of acute admittances to hospital care (2) and the costs have been estimated to be of the same magnitude as the direct costs for pharmaceutical drugs. Discrepancies between medical records and patients stated current medication are common (3-5).

E-prescribing, from physicians’ electronic medical record (EMR) directly to the pharmacies, constitute >75% of all prescriptions in Sweden and >70% of patients in Sweden store their prescriptions electronically in the national prescription repository (NPR), accessible from any pharmacy in Sweden. New e-prescriptions are automatically stored in the NPR. Prescriptions are stored in the NPR as long as a new dispensing is allowed. Patients can receive a printout at any pharmacy with information on the stored prescriptions or see them via a personnel code via Internet.

Of legal reasons, physicians are only allowed to see the prescriptions stored in the NPR if the patient chooses to let the doctor see them.

Physicians are neither able, nor allowed to institute any changes in the stored prescriptions.

Pharmacists are able and allowed to make changes in or destroy the stored prescriptions, but on patient demand only. Consequently, the NPR may contain both prescriptions for current actual treatment and for non-current, previously changed or terminated treatment as well as prescription duplicates. For patients with many medications and/or many changes in the treatment the risk for mistakes and medication errors may be increased.

Objective: The objective was to compare the prescribed current treatment stated by patients with chronic diseases with (a) the data on prescribed treatment in the EMR and stored prescriptions in the NPR, and (b) study the presence of prescriptions for non-current (changed or terminated) treatment, prescription duplicates and prescriptions for “double medication” in the EMR and the NPR.

Design: Cross-sectional study. Patients, over 18 years of age with diagnoses of either chronic heart failure (CHF), diabetes mellitus (IDDM or NIDDM) or arthrosis and a prescribed treatment with 5 drugs in the EMR. Patients with more than one of the diagnoses were included in the order 1/CHF, 2/diabetes and 3/arthrosis.

A random sample of patients received an invitational letter to the study. Patients giving written informed consent to participate were interviewed on their prescribed current treatment and compared with printouts of the prescribed treatment from the EMR and stored prescriptions in the NPR. The prescriptions were classified as a/

current, actual treatment or b/ non-current, previously changed or terminated treatment.

Prescription duplicates (identical prescribed treatment with regard to substance, administration formula, strength and dosage) and prescriptions for double medication (prescriptions for the same symptom but differing with respect to prescribed strength, dosage or substance), were identified.

Setting: Patients listed at one Health Care Central in Kalmar in south Sweden. The patients were interviewed by telephone during February 2010.

Main Outcome Measures: Proportions of prescriptions for (a) non-current treatments that had been changed or terminated, (b) prescription duplicates and (c) “double medication" in the NPR.

Results: Of 161 invited patients (50 diabetics, 61 with CHF and 50 with arthrosis) 78 patients with 787 prescriptions gave written informed consent to participate. Sixty-seven patients (88%) had at least one non-current prescription, prescription duplicate or prescription for double medication in the NPR. Of the prescribed current treatment stated by the patients, 88.5 % of the prescriptions were found in the NPR and 82.5% were found in the EMR. However, only 59% were present in both EMR and NPR, the lowest figures seen among those 65-74 years old - see Figure 1 and 2.

Figure 1. Venn-diagram Presence of prescriptions in the EMR and NPR and current medication stated by patients (n=78 patients/ 787prescriptions)

39 28

10

99 121

25 Totalt

787 poster 78 patienter

465 Patientuppgift

(n=624)

Journal (n=710) RR

(n=557)

Current medication (n=624)

EMR (n=710) NPR

(n=557)

Figure 2. Presence of current prescriptions stated by patients In EMR and NPR (n=78 patients/ 787prescriptions)

0,0%

10,0%

20,0%

30,0%

40,0%

50,0%

60,0%

70,0%

80,0%

90,0%

45-64 65-74 75-84 85+

Patient age

Prescriptions

Women Men

Of the 557 prescriptions in NPR, 11% were for non-current (changed or terminated treatment) and 6 % were duplicates - see Figure 3.

Figure 3. Presence of prescriptions for non-current medication, duplicates and double medication in the NPR (n=78 patients, 557 prescriptions)

11%

6%

4%

79%

Non-current Duplicates Double medication Unique current prescriptions

In the EMR, 17% of the 710 prescriptions were for non-current (changed or terminated treat- ment), 5 % were duplicates and 3 % double medication - see Figure 4.

Figure 4. Presence of prescriptions for “non-current medication”, duplicates and ”double medication” in the EMR (n=78 patients, 710 prescriptions).

17%

5%

3%

75%

Non-current Duplicates Double medication

Unique current prescriptions

Discussion: Prescriptions for non-current treatment and prescription duplicates are common. Almost nine out of ten patients had at least one non-current prescription or duplicate prescription in the EMR and the NPR. The results are consistent with the findings that discrepancies between EMRs and claims data on the one hand and patient reported current medication use on the other, are common (3-5). Both the printouts from the EMR of the prescribed drug treatment and of the prescriptions stored in the NPR generate prescription records with brand names used by the prescriber when issuing the prescriptions. However, due to mandatory generic substitution in Sweden, other brands/product names may have been dispensed.

Patients with many medications and/or frequent changes in the prescribed treatment may have difficulties to keep record of and adhere to the current prescribed treatment. Missing prescriptions as well as the occurrence of prescriptions for non-current therapy and prescription duplicates and conflicting information on current prescribed drug treatment is a source for medication mistakes and errors which may be aggravated by the mandatory generic substitution.

However, according to our knowledge, there are yet no studies determining to what extent this contribute to adverse drug reactions and acute admissions due to drug related problems

Conclusions: Prescriptions for non-current treatment that previously has been changed or terminated and prescription duplicates are common in both EMR and the Swedish NPR. The risk for medication errors in the open care setting may be substantial.

References:

1. Adherence to long-term therapies: evidence for action.

WHO, 2003.

2. Fryckstedt J, Asker-Hagelberg C. Drug-related problems common at the medical acute care clinic – the cause of admission for almost one-third of patients.

[Läkemedelsrelaterade problem vanliga på medicinakuten - Orsak till inläggning hos nästan var tredje patient, enligt kvalitetsuppföljning] Läkartidningen 2008; 105(12-13):

894-8

3. Bedell SE, Jabbour S, Goldberg R, Glaser H, Gobble S, Young-Xu Y, et.al. Discrepancies in the use of medications. Arch Intern Med. 2000;160 (14):2129–34 4. Orrico, Kathleen B. Sources and Types of Discrepancies Between Electronic Medical Records and Actual Outpatient Medication Use. Journal of Managed Care Pharmacy 2008; 14 (7): 626-31

5. Warholak TL, McCulloch M, Baumgart A, Smith M, Fink W, Fritz W. An exploratory comparison of medication lists at hospital admission with administrative database records. J Manag Care Pharm. 2009 Nov;15(9):751-8.

Correspondence to:

Anders Ekedahl (Associate professor, Pharmacy Practice Research)

R&D Department Apoteket AB c/o Apoteket Lejonet Stortorget 8 SE 211 34 Malmö Sweden

e-mail: anders.ekedahl@apoteket.se

References

Related documents

46 Konkreta exempel skulle kunna vara främjandeinsatser för affärsänglar/affärsängelnätverk, skapa arenor där aktörer från utbuds- och efterfrågesidan kan mötas eller

The increasing availability of data and attention to services has increased the understanding of the contribution of services to innovation and productivity in

Generella styrmedel kan ha varit mindre verksamma än man har trott De generella styrmedlen, till skillnad från de specifika styrmedlen, har kommit att användas i större

Närmare 90 procent av de statliga medlen (intäkter och utgifter) för näringslivets klimatomställning går till generella styrmedel, det vill säga styrmedel som påverkar

I dag uppgår denna del av befolkningen till knappt 4 200 personer och år 2030 beräknas det finnas drygt 4 800 personer i Gällivare kommun som är 65 år eller äldre i

Detta projekt utvecklar policymixen för strategin Smart industri (Näringsdepartementet, 2016a). En av anledningarna till en stark avgränsning är att analysen bygger på djupa

DIN representerar Tyskland i ISO och CEN, och har en permanent plats i ISO:s råd. Det ger dem en bra position för att påverka strategiska frågor inom den internationella

Industrial Emissions Directive, supplemented by horizontal legislation (e.g., Framework Directives on Waste and Water, Emissions Trading System, etc) and guidance on operating